Bertrand Jean-Claude - Search Results

Year	Number of Results
2002	4
2003	6
2004	6
2005	9
2006	8
2007	8
2008	3
2009	4
2010	7
2011	9
2012	5
2013	1
2014	1
2015	5
2016	3
2017	5
2018	3
2019	5
2020	3
2021	3
2022	1
2023	2
2024	0

1

Molecular Profiling of Peanut under Raw, Roasting, and Autoclaving Conditions Using High-Resolution Magic Angle Spinning and Solution ¹H NMR Spectroscopy.

Cohen CG, Mazer BD, Jean-Claude BJ. Cohen CG, et al. Among authors: jean claude bj. Molecules. 2023 Dec 27;29(1):162. doi: 10.3390/molecules29010162. Molecules. 2023. PMID: 38202743 Free PMC article.

2

Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model.

Facchin C, Fraga-Timiraos AB, Schmitt J, Babaa N, Pannu N, Aliaga A, Larroque AL, Jean-Claude BJ. Facchin C, et al. Among authors: jean claude bj. Cells. 2023 Mar 16;12(6):914. doi: 10.3390/cells12060914. Cells. 2023. PMID: 36980255 Free PMC article.

3

Discordance and Concordance Between Cerebrospinal and [¹⁸F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases.

Quispialaya KM, Therriault J, Aliaga A, Zimmermann M, Fernandez-Arias J, Lussier F, Massarweh G, Pascoal T, Soucy JP, Gauthier S, Jean-Claude B, Gilfix B, Vitali P, Rosa-Neto P. Quispialaya KM, et al. Among authors: jean claude b. Neurology. 2022 Nov 29;99(22):e2428-e2436. doi: 10.1212/WNL.0000000000201198. Epub 2022 Oct 20. Neurology. 2022. PMID: 36266044 Free PMC article.

4

Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting.

Rao S, Thibault B, Peyrard L, Larroque-Lombard AL, Rupp M, Thauvin C, Jean-Claude BJ. Rao S, et al. Among authors: jean claude bj. Int J Mol Sci. 2021 Sep 3;22(17):9569. doi: 10.3390/ijms22179569. Int J Mol Sci. 2021. PMID: 34502481 Free PMC article.

5

Design and Mechanism of Action of a New Prototype of Combi-Molecule "Programed" to Release Bioactive Species at a pH Range Akin to That of the Tumor Microenvironment.

Larroque-Lombard AL, Chatelut E, Delord JP, Imbs DC, Rochaix P, Jean-Claude B, Allal B. Larroque-Lombard AL, et al. Among authors: jean claude b. Pharmaceuticals (Basel). 2021 Feb 16;14(2):160. doi: 10.3390/ph14020160. Pharmaceuticals (Basel). 2021. PMID: 33669415 Free PMC article.

6

Subcellular distribution and mechanism of action of AL906, a novel and potent EGFR inhibitor rationally designed to be green fluorescent.

Golabi N, Larroque AL, Peyrard L, Williams C, Jean-Claude BJ. Golabi N, et al. Among authors: jean claude bj. Invest New Drugs. 2021 Feb;39(1):240-250. doi: 10.1007/s10637-020-00958-7. Epub 2020 Jul 9. Invest New Drugs. 2021. PMID: 32648119

7

Design and Synthesis of a Trifunctional Molecular System "Programmed" to Block Epidermal Growth Factor Receptor Tyrosine Kinase, Induce High Levels of DNA Damage, and Inhibit the DNA Repair Enzyme (Poly(ADP-ribose) Polymerase) in Prostate Cancer Cells.

Schmitt J, Huang S, Goodfellow E, Williams C, Jean-Claude BJ. Schmitt J, et al. Among authors: jean claude bj. J Med Chem. 2020 Jun 11;63(11):5752-5762. doi: 10.1021/acs.jmedchem.9b02008. Epub 2020 Jun 2. J Med Chem. 2020. PMID: 32484346

8

Comparative analysis of the dual EGFR-DNA targeting and growth inhibitory properties of 6-mono-alkylamino- and 6,6-dialkylaminoquinazoline-based type II combi-molecules.

Schmitt J, Goodfellow E, Huang S, Williams C, Gomes INF, Rosa MN, Reis RM, Yang R, Titi HM, Jean-Claude BJ. Schmitt J, et al. Among authors: jean claude bj. Eur J Med Chem. 2020 Apr 15;192:112185. doi: 10.1016/j.ejmech.2020.112185. Epub 2020 Feb 26. Eur J Med Chem. 2020. PMID: 32145644

9

Temporal Effects of Quercetin on Tight Junction Barrier Properties and Claudin Expression and Localization in MDCK II Cells.

Gamero-Estevez E, Andonian S, Jean-Claude B, Gupta I, Ryan AK. Gamero-Estevez E, et al. Among authors: jean claude b. Int J Mol Sci. 2019 Oct 2;20(19):4889. doi: 10.3390/ijms20194889. Int J Mol Sci. 2019. PMID: 31581662 Free PMC article.

10

Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.

Sharifi Z, Abdulkarim B, Meehan B, Rak J, Daniel P, Schmitt J, Lauzon N, Eppert K, Duncan HM, Petrecca K, Guiot MC, Jean-Claude B, Sabri S. Sharifi Z, et al. Among authors: jean claude b. Clin Cancer Res. 2019 Dec 15;25(24):7594-7608. doi: 10.1158/1078-0432.CCR-19-0955. Epub 2019 Sep 20. Clin Cancer Res. 2019. PMID: 31540977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year